SCHEMBL5250834

SCHEMBL5250834

CCOc1cccc(C([NH])=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 4/20 0.56
KMT2A Q03164 3/20 0.56
MAPT P10636 3/20 0.56
ALOX12 P18054 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
ALOX15 P16050 1/20 0.56
RECQL P46063 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LMNA P02545 4/20 0.55
MAPK1 P28482 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
NR1H4 Q96RI1 1/20 0.55
HTT P42858 1/20 0.55
RXRA P19793 1/20 0.54
RXRB P28702 1/20 0.54
RAB9A P51151 4/20 0.54
NPC1 O15118 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7769343 0.86 KMT2A (0.73) SMN1; SMN2ALDH1A1KMT2AMAPTMEN1
SCHEMBL5139133 0.85 HPGD (0.68) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL7765680 0.85 THRB (0.63) KMT2AMEN1MAPK1NR1H4KAT6A
SCHEMBL307233 0.84 KMT2A (0.75) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL29505938 0.84 KMT2A (0.75) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL1333545 0.84 KMT2A (0.75) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL29505934 0.84 KMT2A (0.75) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL11044058 0.82 HPGD (0.56) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL364241 0.82 HPGD (0.56) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL2705442 0.82 PARP1 (0.66) HPGDSMN1; SMN2ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1832586-A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas Oridis Biomed Forschungs- und Entwicklungs GmbH (AT) 2007-09-12 EP claimed
EP-1832586-A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas Oridis Biomed Forschungs- und Entwicklungs GmbH (AT) 2007-09-12 EP disclosed
US-6331628-B1 REACTING A SUBSTITUTED HALOBENZENE WITH POTASSIUM, SODIUM AND/OR ZINC CYANIDE IN THE PRESENCE OF A METALLIC CATALYST NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2001-12-18 US disclosed
EP-0765879-B1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO CO (JP) 2001-02-14 EP disclosed
US-5861429-A MITICIDES AND ANTHELMINTICS SANKYO COMPANY, LIMITED (JP) 1999-01-19 US disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 EP disclosed